These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 8324748)

  • 1. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro.
    Ozbun MA; Jerry DJ; Kittrell FS; Medina D; Butel JS
    Cancer Res; 1993 Apr; 53(7):1646-52. PubMed ID: 8453637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
    Medina D; Kittrell FS; Oborn CJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutations in mouse mammary epithelial cells: instability in culture and discordant selection of mutations in vitro versus in vivo.
    Ozbun MA; Medina D; Butel JS
    Cell Growth Differ; 1993 Oct; 4(10):811-9. PubMed ID: 8274450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological and functional properties of TM preneoplastic mammary outgrowths.
    Medina D; Kittrell FS; Liu YJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):663-7. PubMed ID: 7678778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of pregnancy-specific genes in preneoplastic mouse mammary tissues from virgin mice.
    Smith GH; Vonderhaar BK; Graham DE; Medina D
    Cancer Res; 1984 Aug; 44(8):3426-37. PubMed ID: 6430550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and genetic properties of the p53 null preneoplastic mammary epithelium.
    Medina D; Kittrell FS; Shepard A; Stephens LC; Jiang C; Lu J; Allred DC; McCarthy M; Ullrich RL
    FASEB J; 2002 Jun; 16(8):881-3. PubMed ID: 11967232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice.
    Jerry DJ; Butel JS; Donehower LA; Paulson EJ; Cochran C; Wiseman RW; Medina D
    Mol Carcinog; 1994 Mar; 9(3):175-83. PubMed ID: 8142019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
    Kumar R; Medina D; Sukumar S
    Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.
    Ruggeri B; Caamano J; Goodrow T; DiRado M; Bianchi A; Trono D; Conti CJ; Klein-Szanto AJ
    Cancer Res; 1991 Dec; 51(24):6615-21. PubMed ID: 1742735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of differentiation-specific proteins in preneoplastic mammary tissues in BALB/c mice.
    Medina D; Schwartz M; Taha M; Oborn CJ; Smith GH
    Cancer Res; 1987 Sep; 47(17):4686-93. PubMed ID: 3621162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
    Lee CH; Kweon OK
    J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.
    Cui XS; Donehower LA
    Oncogene; 2000 Dec; 19(52):5988-96. PubMed ID: 11146550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
    Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations in bladder carcinoma cell lines.
    Cooper MJ; Haluschak JJ; Johnson D; Schwartz S; Morrison LJ; Lippa M; Hatzivassiliou G; Tan J
    Oncol Res; 1994; 6(12):569-79. PubMed ID: 7787250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression.
    Kastrinakis WV; Ramchurren N; Rieger KM; Hess DT; Loda M; Steele G; Summerhayes IC
    Oncogene; 1995 Aug; 11(4):647-52. PubMed ID: 7651727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
    Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
    Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
    Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.